|
OXCT1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.10462807976364E-15 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.99760216648792E-15 |
| Normal-vs-Stage2 |
1.257430E-01 |
| Normal-vs-Stage3 |
1.97519778311062E-12 |
| Normal-vs-Stage4 |
1.62481139653892E-12 |
| Stage1-vs-Stage2 |
5.348300E-02 |
| Stage1-vs-Stage3 |
9.905600E-01 |
| Stage1-vs-Stage4 |
3.716300E-02 |
| Stage2-vs-Stage3 |
5.844400E-02 |
| Stage2-vs-Stage4 |
9.200600E-03 |
| Stage3-vs-Stage4 |
7.478400E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.44089209850063E-16 |
| Normal-vs-AfricanAmerican |
7.32370053491138E-10 |
| Normal-vs-Asian |
4.10389999760952E-09 |
| Caucasian-vs-AfricanAmerican |
6.186400E-01 |
| Caucasian-vs-Asian |
8.711000E-01 |
| AfricanAmerican-vs-Asian |
7.435400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.11022302462516E-16 |
| Normal-vs-Female |
1.96687111042593E-12 |
| Male-vs-Female |
1.925960E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.08277839419679E-13 |
| Normal-vs-Age(41-60Yrs) |
8.88178419700125E-15 |
| Normal-vs-Age(61-80Yrs) |
2.93940000117843E-08 |
| Normal-vs-Age(81-100Yrs) |
8.350800E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.961800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.760200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.125400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.270780E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.011800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.512200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.824200E-01 |
| Classical-VS-Follicular |
2.221300E-03 |
| Classical-VS-Other |
5.392600E-01 |
| Classical-VS-Normal |
1.11022302462516E-16 |
| Tall-VS-Follicular |
7.056100E-02 |
| Tall-VS-Other |
2.787800E-01 |
| Tall-VS-Normal |
7.11819999610341E-08 |
| Follicular-VS-Other |
1.926120E-02 |
| Follicular-VS-Normal |
4.275400E-03 |
| Other-VS-Normal |
4.43829999996481E-06 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.20097290287913E-12 |
| Normal-vs-N1 |
2.48689957516035E-14 |
| N0-vs-N1 |
1.425510E-02 |
|
|
